Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

62 (26%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DOXAZOSIN 4MG TABLET Resolved 2020-02-05 2020-04-01 105323
APO-DOXAZOSIN 2MG TABLET Resolved 2020-07-23 2020-11-16 120982
APO-DOXAZOSIN 1MG TABLET Resolved 2023-02-09 2023-03-23 184077
APO-DOXAZOSIN 2MG TABLET Resolved 2023-02-23 2023-03-23 185451
APO-DOXY CAP 100MG 100MG CAPSULE Resolved 2021-09-03 2021-09-20 145147
APO-DOXY CAP 100MG 100MG CAPSULE Resolved 2024-03-15 2024-04-05 222414
APO-DOXY CAP 100MG 100MG CAPSULE Resolved 2017-09-04 2017-11-16 20869
APO-DOXY CAP 100MG 100MG CAPSULE Resolved 2018-02-26 2018-05-10 41133
APO-DOXY CAP 100MG 100MG CAPSULE Resolved 2024-05-10 2024-06-21 227728
APO-DOXY TABS 100MG 100MG TABLET Resolved 2017-10-23 2018-02-21 26569
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2023-05-06 2023-06-09 191895
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2023-07-27 2023-08-12 200194
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2023-10-06 2023-11-06 206573
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2023-12-01 2023-12-22 212374
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2024-01-05 2024-01-12 215207
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2024-02-02 2024-03-15 218403
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2024-04-19 2024-05-24 225796
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2024-02-23 2024-03-22 220459
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2017-12-18 2018-07-03 33576
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2019-03-27 2019-05-03 79577

Showing 1041 to 1060 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750

Showing 261 to 280 of 359